AMERICAN SHARED HOSPITAL SER (AMS) Stock Overview
NYSEARCA:AMS - US0295951059 - Common Stock
AMS Key Statistics, Chart & Performance
The current stock price of AMS is 2.51 USD. In the past month the price decreased by -1.26%. In the past year, price decreased by -16.95%.
AMS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.16 | 89.70B | ||
| CI | THE CIGNA GROUP | 10.75 | 80.60B | ||
| LH | LABCORP HOLDINGS INC | 18.32 | 23.04B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.26 | 20.38B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 117.86 | 15.45B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 12.18 | 14.58B | ||
| HIMS | HIMS & HERS HEALTH INC | 62.66 | 11.33B | ||
| DVA | DAVITA INC | 13.99 | 9.69B | ||
| GH | GUARDANT HEALTH INC | N/A | 7.45B | ||
| CHE | CHEMED CORP | 20.91 | 6.81B | ||
| RDNT | RADNET INC | 199.9 | 5.54B | ||
| OPCH | OPTION CARE HEALTH INC | 21.73 | 4.76B |
Related stock screener links
About AMS
Company Profile
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 81 full-time employees. Its segments include Leasing and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its Proton Beam Radiation Therapy Operations is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. Its Gamma Knife stereotactic radiosurgery, a non-invasive procedure, is an alternative to conventional brain surgery and/or radiation therapy. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company can be an adjunct to conventional brain surgery, radiation therapy, or chemotherapy. The firm provides radiation therapy services both domestically and internationally.
Company Info
AMERICAN SHARED HOSPITAL SER
601 Montgomery Street, Suite 1112
San Francisco CALIFORNIA 94111 US
CEO: Raymond C. Stachowiak
Employees: 82
Phone: 14157885300
AMERICAN SHARED HOSPITAL SER / AMS FAQ
What is the stock price of AMERICAN SHARED HOSPITAL SER today?
The current stock price of AMS is 2.51 USD.
What is the ticker symbol for AMERICAN SHARED HOSPITAL SER stock?
The exchange symbol of AMERICAN SHARED HOSPITAL SER is AMS and it is listed on the NYSE Arca exchange.
On which exchange is AMS stock listed?
AMS stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for AMERICAN SHARED HOSPITAL SER stock?
5 analysts have analysed AMS and the average price target is 4.59 USD. This implies a price increase of 82.87% is expected in the next year compared to the current price of 2.51. Check the AMERICAN SHARED HOSPITAL SER stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AMERICAN SHARED HOSPITAL SER worth?
AMERICAN SHARED HOSPITAL SER (AMS) has a market capitalization of 16.34M USD. This makes AMS a Nano Cap stock.
How many employees does AMERICAN SHARED HOSPITAL SER have?
AMERICAN SHARED HOSPITAL SER (AMS) currently has 82 employees.
What are the support and resistance levels for AMERICAN SHARED HOSPITAL SER (AMS) stock?
AMERICAN SHARED HOSPITAL SER (AMS) has a support level at 2.5 and a resistance level at 2.51. Check the full technical report for a detailed analysis of AMS support and resistance levels.
Is AMERICAN SHARED HOSPITAL SER (AMS) expected to grow?
The Revenue of AMERICAN SHARED HOSPITAL SER (AMS) is expected to grow by 9.31% in the next year. Check the estimates tab for more information on the AMS EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AMERICAN SHARED HOSPITAL SER (AMS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AMS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AMS, evaluating the profitability, health, valuation and growth aspects
- AMERICAN SHARED HOSPITAL SER (AMS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AMERICAN SHARED HOSPITAL SER (AMS) Sales and EPS estimates to see what analysts future expectations are.
- AMERICAN SHARED HOSPITAL SER (AMS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AMERICAN SHARED HOSPITAL SER (AMS) Insider and Institutional Ownership to learn about the owners and their transactions.
- AMERICAN SHARED HOSPITAL SER (AMS) Stock Chart to make your own analysis
- AMERICAN SHARED HOSPITAL SER (AMS) Latest news and press-releases to stay up to date.
Does AMERICAN SHARED HOSPITAL SER (AMS) stock pay dividends?
AMS does not pay a dividend.
When does AMERICAN SHARED HOSPITAL SER (AMS) report earnings?
AMERICAN SHARED HOSPITAL SER (AMS) will report earnings on 2025-11-11.
What is the Price/Earnings (PE) ratio of AMERICAN SHARED HOSPITAL SER (AMS)?
AMERICAN SHARED HOSPITAL SER (AMS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).
What is the Short Interest ratio of AMERICAN SHARED HOSPITAL SER (AMS) stock?
The outstanding short interest for AMERICAN SHARED HOSPITAL SER (AMS) is 1.42% of its float. Check the ownership tab for more information on the AMS short interest.
AMS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AMS. When comparing the yearly performance of all stocks, AMS is a bad performer in the overall market: 79.27% of all stocks are doing better.
AMS Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AMS. There are concerns on the financial health of AMS while its profitability can be described as average.
AMS Financial Highlights
Over the last trailing twelve months AMS reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS decreased by -511.11% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 4.93% | ||
| ROA | 2.28% | ||
| ROE | 5.85% | ||
| Debt/Equity | 0.76 |
AMS Forecast & Estimates
5 analysts have analysed AMS and the average price target is 4.59 USD. This implies a price increase of 82.87% is expected in the next year compared to the current price of 2.51.
For the next year, analysts expect an EPS growth of 49.5% and a revenue growth 9.31% for AMS